Raman-Tangella Vidya 4
4 · Teladoc Health, Inc. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Raman-Tangella Vidya
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-05-31−2,325→ 16,277 total→ Common Stock (2,325 underlying) - Sale
Common Stock
2024-05-31$11.21/sh−3,407$38,192→ 28,870 total - Sale
Common Stock
2024-06-04$11.04/sh−468$5,167→ 27,280 total - Exercise/Conversion
Common Stock
2024-05-31+2,325→ 32,277 total - Sale
Common Stock
2024-06-03$11.16/sh−1,122$12,518→ 27,748 total - Exercise/Conversion
Performance Stock Units
2024-05-31−792→ 5,548 total→ Common Stock (792 underlying) - Exercise/Conversion
Common Stock
2024-05-31+792→ 29,952 total
Footnotes (6)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024.
- [F4]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F5]On March 1, 2024, the reporting person earned 9,509 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.